Mechanism of Action:
- Activates mechanisms of cell migration and differentiation
- Stimulates neoangiogenesis in damaged tissues
- Reduces expression of inflammatory cytokines
- Increases extracellular matrix synthesis
Recommended for:
- Professional athletes with ligament injuries
- Patients with long-term non-healing wounds
- Individuals with degenerative joint changes
- After orthopedic surgical interventions
Research and Studies:
Multicenter studies confirm:
- 45% acceleration of tendon healing compared to control group
- 30-40% reduction in inflammatory markers (CRP, IL-6) after 2 weeks of use
- 60% improvement in joint mobility in osteoarthritis
- Clinically significant improvement in diabetic ulcers in 78% of cases
- Rehabilitation after ligament and tendon ruptures
- Treatment of chronic inflammatory joint diseases
- Recovery after sports injuries
- Healing of postoperative wounds and sutures
- Complex therapy of degenerative musculoskeletal diseases
The vial content is dissolved in 1-2 ml of sterile water for injections. The drug is administered subcutaneously close to the injury site. Standard dosage is 2-2.5 mg twice a week. The course duration is determined individually by the attending physician.
Contraindications:
- History of malignant neoplasms
- Autoimmune diseases in active phase
- Pregnancy and breastfeeding
- Hypersensitivity to drug components
- Age under 21 years
Side Effects:
- Transient hyperemia at injection site
- Mild skin itching or tingling
- Temporary increase in blood pressure
- Dizziness during first days of use
